Rybelsus marks a significant advancement in diabetes management, particularly for individuals grappling with Type 2 diabetes. This oral medication, containing semaglutide, distinguishes itself as the first GLP-1 receptor agonist available in pill form. Its mode of action centers around enhancing insulin secretion, reducing appetite, and slowing gastric emptying. Patients experience…